Results 131 to 140 of about 3,637 (213)

Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial. [PDF]

Acta Oncol
Slørdahl KS, Puco K, Falk RS, Dyvik I, Brabrand S, Niehusmann P, Steinskog ESS, Blix ES, Flobak Å, Oppedal IA, Meltzer S, Torkildsen CF, Blakstad H, Lindemann K, Smeland S, Amundsen A, Taskén K, Helland Å, InPred Consortium.   +18 more
europepmc   +1 more source

BRAF ^<b>V600E</b> Metastatic Synovial Sarcoma Treated with BRAF & MEK Inhibitors Achieves Complete Response. A Case Report & Literature Review. [PDF]

Oncol Res
Burg D, Babkoff A, Or O, Olshinka N, Demma JA, Adila M, Wygoda M, Blumenfeld P, Diment J, Galiner M, Azraq Y, Katz D, Reissman P, Ostrowicki S, Sebbag G, Elkhateeb N, Moshe AH, Jaber D, Hollander A, Rubin L, Zick A.   +20 more
europepmc   +1 more source

Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease. [PDF]

Int J Chron Obstruct Pulmon Dis
Siler TM, Rheault T, Reyner D, MacDonald-Berko M, Davidson J, Rickard K.   +5 more
europepmc   +1 more source

Microwave-assisted synthesis and functionalization of 2-arylimidazo[1,2-a]pyrimidin-5(8H)-ones. [PDF]

RSC Adv
Camargo D, Cifuentes C, Castillo JC, Portilla J.   +3 more
europepmc   +1 more source

Synthesis of triazole bridged N-glycosides of pyrazolo[1,5-a]pyrimidinones as anticancer agents and their in silico docking studies. [PDF]

RSC Adv
Tiwari G, Mishra VK, Kumari P, Khanna A, Sharma S, Sagar R.   +5 more
europepmc   +1 more source

An ex vivo functional biomarker of treatment response in pediatric low-grade glioma. [PDF]

PLoS One
Artz NM, Mann B, Ebbs A, Darawsheh R, Dasari R, Adefolaju A, Bell N, Trembath D, Higgins D, Elton S, Baldwin A, Hingtgen S, Kram DE, Satterlee AB.   +13 more
europepmc   +1 more source

臨床分析学 [PDF]

, 1989
宮原 龍郎, 川嶋 洋一, 森 正明, 狐塚 寛   +3 more
core   +1 more source

Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i>^<i>V600E</i> Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H. [PDF]

JCO Precis Oncol
Salama AKS, Wang V, Macrae ER, Park JI, Chen HX, Gray RJ, McShane LM, Rubinstein LV, Patton D, Williams PM, Hamilton SR, Armstrong DK, Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT.   +18 more
europepmc   +1 more source

Response to dabrafenib and trametinib combined with pembrolizumab in an elderly patient with lung adenocarcinoma of unknown primary harboring BRAF V600E mutation and high PD-L1 expression: a case report. [PDF]

Front Immunol
Li N, Hu J, Bao G, Cai Z.
europepmc   +1 more source

Metastatic Low-Grade Glioma Successfully Treated in a Pediatric Patient With BRAF A598_T599insI Mutation. [PDF]

Cancer Rep (Hoboken)
Calò P, Diallo S, Lebrun L, Gilis N, Preziosi M, Leblond P.   +5 more
europepmc   +1 more source